Thane: Bajaj Healthcare has announced the appointment of Shreekumar Shankarnarayan Nair as Chief Operating Officer (COO), ...
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The new ...
Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive. Topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback